Unlock Strategic Intelligence with Fundz
Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.
Viaqua Therapeutics Announces $4.3 Million Investment Led By S2G Ventures For Its Rna-Based Aquaculture Health Platform
Viaqua Therapeutics Announces $4.3 Million Investment Led By S2G Ventures For Its Rna-Based Aquaculture Health Platform
06/09/21, 10:27 AM
Money raised
$4.3 million
Round Type
seed
ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health in aquaculture, announced it has completed a $4.3 million round to commercialize and expand its platform. Multinational new investors include: S2G Ventures (S2G Oceans & Seafood Fund), Thai Union, and Agriline. Earlier investors Nutreco, Visvires New Protein, The Trendlines Group (SGX:42:T;OTCQX: TRNLY) and the Technion Israel Institute of Technology also participated in this round. ViAqua was also awarded additional grant funding from the Israeli Innovation Authority.
🔒 Strategic shifts and deeper insights are available for this company. Unlock full access to view hidden updates, executive moves, and more.
Company Info
Additional Info
ViAqua was established to address the growing need for effective, specific, and affordable health management of diseases in aquaculture. One of the major challenges facing the shift to sustainable aquaculture practice is the prevention and treatment of disease. ViAqua is developing a biotechnology-based, oral delivery platform for administration of nucleic acid-based solutions for promoting health in marine species.
Contact information:Shai Ufaz, Co-founder and CEO, ViAqua Therapeutics[email protected]+972.528430591
SOURCE ViAqua Therapeutics

Track Every New Funding Round — Before Anyone Else
This is just a small preview. Unlock access to thousands more filtered results — updated in real-time by stage, region, investor & more.
Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.